Response to discussant comments on "NMA, the first 20 years".

ABSTRACT

We respond to discussant comments on our paper "Twenty years of network meta-analysis: Continuing controversies and recent developments" (https//doi.org/10.1002/jrsm.1700) and raise some additional points for consideration, including the way in which methodological guidance is generated; integration of the estimand framework with evidence synthesis; and implications of the European Joint Clinical Assessment. We ask what properties are required of population adjustment methods to enable transparent and consistent decision-making? We also ask why individual patient data is not routinely made available to re-imbursement authorities and clinical guideline developers.